Document is current
Any future updates will be listed below
-
Authors
Yin, Huimei https://orcid.org/0000-0003-3624-7016
Cheng, Oumei
Zhang, Xu
Quan, Fengying
Zhang, Yujiao
Zuo, Hongzhou
Zhou, Jianrong https://orcid.org/0000-0002-3612-1264
Xie, Shi-Qi https://orcid.org/0000-0002-4100-1267
-
Funding
Funding for this research was provided by:
Chongqing medical scientific research project (2022MSXM182, 2022MSXM182, 2022MSXM182, 2022MSXM182, 2022MSXM182, 2022MSXM182)
Chongqing Medical University Nursing School 2023 Scientific Research Project (20230303, 20230303)
- License Information
-
More Information
Article History
Received: 9 July 2024
Accepted: 21 January 2025
First Online: 20 February 2025
Declarations
:
: This single-blind randomized controlled trial received approval from the Medical Ethics Committee of the First Affiliated Hospital of Chongqing Medical University (reference No: 2021 − 550) and was retrospectively registered on the Chinese Clinical Trials Registry Platform (Identifier: ChiCTR2200056762). The trial adhered to the Consolidated Standards of Reporting Trials guidelines and followed the ethical standards outlined in the Declaration of Helsinki. All participants provided written informed consent, and their data were anonymized.
: Not Applicable.
: The authors declare no competing interests.
